Skip to main content
Fig. 1 | Cancer Imaging

Fig. 1

From: Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC

Fig. 1

Representation of the percent change in the longitudinal diameter (LD) 3 (a), 6 (b) and 12 (c) months after initiation of therapy. Depending on the therapeutic response the reference value used to determine the percentage change in tumor response according to RECIST 1.1 are baseline or Nadir. All three panels show no statistically significant difference in the assessment of the LD. Values are displayed as mean and SEM

Back to article page